OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC
Dezhi Li, Jie Qin, Tao Zhou, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 4
Open Access | Times Cited: 27
Dezhi Li, Jie Qin, Tao Zhou, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 4
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 14
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 14
Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Christos Triantos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2631-2631
Open Access | Times Cited: 13
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Christos Triantos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2631-2631
Open Access | Times Cited: 13
Chimeric antigen receptor-T cells targeting AFP-GPC3 mediate increased antitumor efficacy in hepatocellular carcinoma
Mingxing Li, Chen Tian, Rongshi Huang, et al.
Arab Journal of Gastroenterology (2025)
Closed Access | Times Cited: 1
Mingxing Li, Chen Tian, Rongshi Huang, et al.
Arab Journal of Gastroenterology (2025)
Closed Access | Times Cited: 1
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells
Minghao Sui, Tiantian Liu, Xinyue Song, et al.
Pharmacological Research (2025), pp. 107619-107619
Open Access | Times Cited: 1
Minghao Sui, Tiantian Liu, Xinyue Song, et al.
Pharmacological Research (2025), pp. 107619-107619
Open Access | Times Cited: 1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 17
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 17
GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma
Lili Guan, Shanshan Wu, Qinyao Zhu, et al.
Biochemistry and Biophysics Reports (2024) Vol. 39, pp. 101741-101741
Open Access | Times Cited: 4
Lili Guan, Shanshan Wu, Qinyao Zhu, et al.
Biochemistry and Biophysics Reports (2024) Vol. 39, pp. 101741-101741
Open Access | Times Cited: 4
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
Arnaud Couzinet, Toshihiro Suzuki, Tetsuya Nakatsura
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 10, pp. 895-909
Closed Access | Times Cited: 4
Arnaud Couzinet, Toshihiro Suzuki, Tetsuya Nakatsura
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 10, pp. 895-909
Closed Access | Times Cited: 4
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression
Mingzhen Zhou, Ziyan Zhou, Lina Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Mingzhen Zhou, Ziyan Zhou, Lina Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Heparan sulfate chains in hepatocellular carcinoma
Erwan Guyot
Gastroenterology report (2025) Vol. 13
Open Access
Erwan Guyot
Gastroenterology report (2025) Vol. 13
Open Access
T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Glypican3 and Serglycin as Potential Biomarkers Involved in the Pathogenesis of Ovarian Endometriosis
Hasnaa Hassan Hassanein, Amr Ahmed WalyEldeen, R. M. Sayed, et al.
Tissue and Cell (2025), pp. 102867-102867
Closed Access
Hasnaa Hassan Hassanein, Amr Ahmed WalyEldeen, R. M. Sayed, et al.
Tissue and Cell (2025), pp. 102867-102867
Closed Access
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access
Development of a model combining CEUS LI-RADS and clinical features for predicting glypican-3 expression in hepatocellular carcinoma
Fen Huang, Jin-shu Pang, Yuquan Wu, et al.
Abdominal Radiology (2025)
Closed Access
Fen Huang, Jin-shu Pang, Yuquan Wu, et al.
Abdominal Radiology (2025)
Closed Access
Bispecific c-Met/PD-1 CAR-T Cells Have Enhanced Therapeutic Effects on Solid Tumor
HuanRan Yang, Yanjun Zhang, YanQiu Li, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
HuanRan Yang, Yanjun Zhang, YanQiu Li, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours
Chelsea Taylor, Maya Glover, John Maher
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 849-871
Open Access | Times Cited: 3
Chelsea Taylor, Maya Glover, John Maher
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 849-871
Open Access | Times Cited: 3
Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma
A García, Stephen O. Mathew
Cancers (2024) Vol. 16, Iss. 13, pp. 2446-2446
Open Access | Times Cited: 2
A García, Stephen O. Mathew
Cancers (2024) Vol. 16, Iss. 13, pp. 2446-2446
Open Access | Times Cited: 2
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies
Gurpreet Kandav, Akash Chandel
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 1
Gurpreet Kandav, Akash Chandel
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 1
Advances and considerations in the use of immunotherapies for primary hepato-biliary malignancies
Leva Gorji, Zachary J. Brown, Timothy M. Pawlik
Surgical Oncology (2023) Vol. 52, pp. 102031-102031
Closed Access | Times Cited: 2
Leva Gorji, Zachary J. Brown, Timothy M. Pawlik
Surgical Oncology (2023) Vol. 52, pp. 102031-102031
Closed Access | Times Cited: 2
Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1/CD28 Fusion Receptors Produced Using a Lentiviral Vector
Heon Ju Lee, Seo Jin Hwang, Eun Hee Jeong, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 7, pp. 555-568
Open Access
Heon Ju Lee, Seo Jin Hwang, Eun Hee Jeong, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 7, pp. 555-568
Open Access
Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma
Tuo Ren, Y. B. Huang
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Tuo Ren, Y. B. Huang
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
